德英生物科技
News

Events

2026.08.12

Events

G&E Biotechnology meets with overseas buyers

at Taiwan Health Industry Sourcing Day

 

We were delighted to connect with overseas buyers and industry professionals at the Taiwan Health Industry Sourcing Day organized by TAITRA. G&E’s enhanced silymarin innovation for international markets – HepaGent™ attracted strong attention and received highly positive feedback. We’re excited to continue exploring partnerships and welcome inquiries regarding international distribution opportunities.

Key Highlights of HepaGent™:

◆ Targeted support for liver repair, NAFLD, CKD, and blood sugar stabilization

◆ Achieves up to 35× higher blood concentration compared to other commercial products

◆ 92–99% dissolution rate, exceeding the USP ≥75% standard and outperforming global competitors

◆ Formulated with no special excipients, fully compliant with global food regulations

◆ 100% plant-based, suitable for vegetarians

#HepaGent #Liversolution #PharmaceuticalManufacturing #Botanicals #MadeinTaiwan #GnE #herbal #德英生技 #TAITRA